Benefits of PCI–Capable Facility Openings Vary by Race, Community
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 15, 2023 -- There are differential benefits associated with a percutaneous coronary intervention–capable facility (PCI-CF) opening based on patient race and community segregation, according to a research letter published online Dec. 12 in JAMA Network Open.
Renee Y. Hsia, M.D., from University of California, San Francisco, and Yu-Chu Shen, Ph.D., from the Naval Postgraduate School in Monterey, California, examined differential changes in patient outcomes after PCI-CF openings by patient race and community segregation. Analysis included 2.39 million patients with Medicare Fee-for-Service and acute myocardial infarction (AMI; 2006 through 2017).
The researchers found that patients in integrated communities had larger increases in their probability of PCI during a hospitalization (Black patients: 6.62 percentage points and White patients: 5.28 percentage points) versus those in segregated communities (3.60 percentage points and 2.20 percentage points for Black and White patients, respectively) after a PCI-CF opening. These changes yield a 12.3 percent relative increase for Black patients in integrated communities and a 3.5 percent relative increase for White patients in segregated communities. For 30-day mortality, Black patients in integrated communities had a 1.30 percentage point decrease (roughly 10.7 percent relative decrease), which persisted at one year (1.86 percentage point decrease, or 6.2 percent relative decrease) after a PCI-CF opening.
"Our findings reveal potential avenues for improving PCI resource allocation, including the implementation of public health measures or financial incentives to support PCI-CF openings in majority Black and integrated communities and greater structural reform targeting the built environment of health care services," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older
TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.